Company Search:
Advanced Search
Sponsored Links
Orexo Ab - ADR Company Snapshot
Orexo Ab operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Orexo Ab with three other companies in this sector in UNITED STATES : Athenex Inc (2019 sales of $101.23 million of which 50% was Commercial Platform), ImmunoGen, Inc. ($82.27 million of which 100% was Cancer Therapeutics), and MusclePharm Corp ($79.67 million ).

Sales Analysis. During the year ended December of 2019, sales at Orexo Ab were $89.17 million. This is a decrease of 0.6% versus 2018, when the company's sales were $89.68 million. The sales level in 2019 was fairly close to the level five years ago: in 2014, Orexo Ab had sales of $82.71 million.
  Stock Performance Chart for Orexo Ab - ADR
  Stock Data: Recent Stock Performance:
  Current Price (8/24/2020): 5.60
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
Orexo Ab - ADR Key Data:
  Ticker: ORXOY Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 89,168,640
(Year Ending Jan 2020).
Employees: 127
  Currency: U.S. Dollars Market Cap: 198,747,416
  Fiscal Yr Ends: December Shares Outstanding: 35,490,610
  Share Type: Common Closely Held Shares: 3,659,071
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.